| Infinity Home Health Care, Inc | |
| 4001 W Devon Avenue Suite 336., Chicago, Illinois 60646 | |
| (847) 983-0979 | |
| Name | Infinity Home Health Care, Inc |
|---|---|
| Location | 4001 W Devon Avenue Suite 336., Chicago, Illinois |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 147834 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 60016, 60073, 60104, 60164, 60172, 60176, 60409, 60419, 60423, 60426, 60443, 60445, 60477, 60608, 60609, 60615, 60616, 60617, 60618, 60619, 60620, 60622, 60623, 60624, 60625, 60628, 60630, 60634, 60639, 60640, 60644, 60645, 60646, 60647, 60649, 60651, 60659, 60660, 60707, 60712, 60804 |
| NPI Number | 1841388790 |
| Organization Name | INFINITY HOME HEALTH CARE, INC |
| Address | 3315 Algonquin Rd Ste 410, Rolling Meadows, IL 60008 |
| Phone Number | 847-983-0979 |
News Archive
Australian biopharmaceutical company Immuron Limited has today announced a significant milestone in its Phase 2 clinical trial for non-alcoholic steatohepatitis (NASH) with the recruitment of its first two patients at Duke University in the United States. It is expected that further recruitment at Duke and other sites in the US and Australia will follow in early course.
In a Review published in The Lancet Neurology, two of the world's leading experts on the link between environment and children's health are sounding the alarm on the dangers of industrial chemicals. They are calling on countries to transform their chemical risk-assessment procedures in order to protect children from everyday toxins that may be causing a global "silent epidemic" of brain development disorders.
Community Anti-Drug Coalitions of America (CADCA) applauds Senators Chris Dodd (D-CT), Frank Lautenberg (D-NJ), Bob Casey (D-PA), and Jeff Merkley (D-OR), for today introducing the Sober Truth on Preventing (STOP) Underage Drinking Act Reauthorization, legislation designed to prevent underage drinking.
Cigna Corporation and HealthSpring, Inc. today announced that they have signed a definitive agreement under which Cigna will acquire all the outstanding shares of HealthSpring for $55 per share in cash, a 37% premium over the closing stock price on Friday October 21, 2011, representing a total transaction value of approximately $3.8 billion.
American Pharmaceutical Partners, Inc. today announced it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Cladribine Injection.
› Verified 4 days ago
| NPI Number | 1891418950 |
| Organization Name | INFINITY HOME HEALTH CARE, INC |
| Address | 3315 Algonquin Rd Ste 410, Rolling Meadows, IL 60008 |
| Phone Number | 847-983-0979 |
News Archive
Australian biopharmaceutical company Immuron Limited has today announced a significant milestone in its Phase 2 clinical trial for non-alcoholic steatohepatitis (NASH) with the recruitment of its first two patients at Duke University in the United States. It is expected that further recruitment at Duke and other sites in the US and Australia will follow in early course.
In a Review published in The Lancet Neurology, two of the world's leading experts on the link between environment and children's health are sounding the alarm on the dangers of industrial chemicals. They are calling on countries to transform their chemical risk-assessment procedures in order to protect children from everyday toxins that may be causing a global "silent epidemic" of brain development disorders.
Community Anti-Drug Coalitions of America (CADCA) applauds Senators Chris Dodd (D-CT), Frank Lautenberg (D-NJ), Bob Casey (D-PA), and Jeff Merkley (D-OR), for today introducing the Sober Truth on Preventing (STOP) Underage Drinking Act Reauthorization, legislation designed to prevent underage drinking.
Cigna Corporation and HealthSpring, Inc. today announced that they have signed a definitive agreement under which Cigna will acquire all the outstanding shares of HealthSpring for $55 per share in cash, a 37% premium over the closing stock price on Friday October 21, 2011, representing a total transaction value of approximately $3.8 billion.
American Pharmaceutical Partners, Inc. today announced it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Cladribine Injection.
› Verified 4 days ago
| Quality Rating: |
News Archive
Australian biopharmaceutical company Immuron Limited has today announced a significant milestone in its Phase 2 clinical trial for non-alcoholic steatohepatitis (NASH) with the recruitment of its first two patients at Duke University in the United States. It is expected that further recruitment at Duke and other sites in the US and Australia will follow in early course.
In a Review published in The Lancet Neurology, two of the world's leading experts on the link between environment and children's health are sounding the alarm on the dangers of industrial chemicals. They are calling on countries to transform their chemical risk-assessment procedures in order to protect children from everyday toxins that may be causing a global "silent epidemic" of brain development disorders.
Community Anti-Drug Coalitions of America (CADCA) applauds Senators Chris Dodd (D-CT), Frank Lautenberg (D-NJ), Bob Casey (D-PA), and Jeff Merkley (D-OR), for today introducing the Sober Truth on Preventing (STOP) Underage Drinking Act Reauthorization, legislation designed to prevent underage drinking.
Cigna Corporation and HealthSpring, Inc. today announced that they have signed a definitive agreement under which Cigna will acquire all the outstanding shares of HealthSpring for $55 per share in cash, a 37% premium over the closing stock price on Friday October 21, 2011, representing a total transaction value of approximately $3.8 billion.
American Pharmaceutical Partners, Inc. today announced it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Cladribine Injection.
› Verified 4 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 80.7 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 97.5 | 98.6 |
| How often the home health team checked patients’ risk of falling | 99 | 99.6 |
| How often the home health team checked patients for depression | 100 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 69.9 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 62.2 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 97.6 | 96.4 |
News Archive
Australian biopharmaceutical company Immuron Limited has today announced a significant milestone in its Phase 2 clinical trial for non-alcoholic steatohepatitis (NASH) with the recruitment of its first two patients at Duke University in the United States. It is expected that further recruitment at Duke and other sites in the US and Australia will follow in early course.
In a Review published in The Lancet Neurology, two of the world's leading experts on the link between environment and children's health are sounding the alarm on the dangers of industrial chemicals. They are calling on countries to transform their chemical risk-assessment procedures in order to protect children from everyday toxins that may be causing a global "silent epidemic" of brain development disorders.
Community Anti-Drug Coalitions of America (CADCA) applauds Senators Chris Dodd (D-CT), Frank Lautenberg (D-NJ), Bob Casey (D-PA), and Jeff Merkley (D-OR), for today introducing the Sober Truth on Preventing (STOP) Underage Drinking Act Reauthorization, legislation designed to prevent underage drinking.
Cigna Corporation and HealthSpring, Inc. today announced that they have signed a definitive agreement under which Cigna will acquire all the outstanding shares of HealthSpring for $55 per share in cash, a 37% premium over the closing stock price on Friday October 21, 2011, representing a total transaction value of approximately $3.8 billion.
American Pharmaceutical Partners, Inc. today announced it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Cladribine Injection.
› Verified 4 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 60.3 | 79.6 |
| How often patients got better at getting in and out of bed | 66.6 | 81.1 |
| How often patients got better at bathing | 60 | 82.3 |
| How often patients’ breathing improved | 72.9 | 82.8 |
| How often patients’ wounds improved or healed after an operation | - | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 51.1 | 75 |
| How often home health patients had to be admitted to the hospital | 11.9 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 9.9 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 73.9 | 94 |
News Archive
Australian biopharmaceutical company Immuron Limited has today announced a significant milestone in its Phase 2 clinical trial for non-alcoholic steatohepatitis (NASH) with the recruitment of its first two patients at Duke University in the United States. It is expected that further recruitment at Duke and other sites in the US and Australia will follow in early course.
In a Review published in The Lancet Neurology, two of the world's leading experts on the link between environment and children's health are sounding the alarm on the dangers of industrial chemicals. They are calling on countries to transform their chemical risk-assessment procedures in order to protect children from everyday toxins that may be causing a global "silent epidemic" of brain development disorders.
Community Anti-Drug Coalitions of America (CADCA) applauds Senators Chris Dodd (D-CT), Frank Lautenberg (D-NJ), Bob Casey (D-PA), and Jeff Merkley (D-OR), for today introducing the Sober Truth on Preventing (STOP) Underage Drinking Act Reauthorization, legislation designed to prevent underage drinking.
Cigna Corporation and HealthSpring, Inc. today announced that they have signed a definitive agreement under which Cigna will acquire all the outstanding shares of HealthSpring for $55 per share in cash, a 37% premium over the closing stock price on Friday October 21, 2011, representing a total transaction value of approximately $3.8 billion.
American Pharmaceutical Partners, Inc. today announced it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Cladribine Injection.
› Verified 4 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | Not Available |
| Health team communicated well with them | Not Available |
| Health team discussed medicines, pain, and home safety | Not Available |
| How patients rated overall care from agency | Not Available |
News Archive
Australian biopharmaceutical company Immuron Limited has today announced a significant milestone in its Phase 2 clinical trial for non-alcoholic steatohepatitis (NASH) with the recruitment of its first two patients at Duke University in the United States. It is expected that further recruitment at Duke and other sites in the US and Australia will follow in early course.
In a Review published in The Lancet Neurology, two of the world's leading experts on the link between environment and children's health are sounding the alarm on the dangers of industrial chemicals. They are calling on countries to transform their chemical risk-assessment procedures in order to protect children from everyday toxins that may be causing a global "silent epidemic" of brain development disorders.
Community Anti-Drug Coalitions of America (CADCA) applauds Senators Chris Dodd (D-CT), Frank Lautenberg (D-NJ), Bob Casey (D-PA), and Jeff Merkley (D-OR), for today introducing the Sober Truth on Preventing (STOP) Underage Drinking Act Reauthorization, legislation designed to prevent underage drinking.
Cigna Corporation and HealthSpring, Inc. today announced that they have signed a definitive agreement under which Cigna will acquire all the outstanding shares of HealthSpring for $55 per share in cash, a 37% premium over the closing stock price on Friday October 21, 2011, representing a total transaction value of approximately $3.8 billion.
American Pharmaceutical Partners, Inc. today announced it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Cladribine Injection.
› Verified 4 days ago
The patient survey data of Infinity Home Health Care, Inc is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 86 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 83 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 92 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 81 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 63 | 78 |
News Archive
Australian biopharmaceutical company Immuron Limited has today announced a significant milestone in its Phase 2 clinical trial for non-alcoholic steatohepatitis (NASH) with the recruitment of its first two patients at Duke University in the United States. It is expected that further recruitment at Duke and other sites in the US and Australia will follow in early course.
In a Review published in The Lancet Neurology, two of the world's leading experts on the link between environment and children's health are sounding the alarm on the dangers of industrial chemicals. They are calling on countries to transform their chemical risk-assessment procedures in order to protect children from everyday toxins that may be causing a global "silent epidemic" of brain development disorders.
Community Anti-Drug Coalitions of America (CADCA) applauds Senators Chris Dodd (D-CT), Frank Lautenberg (D-NJ), Bob Casey (D-PA), and Jeff Merkley (D-OR), for today introducing the Sober Truth on Preventing (STOP) Underage Drinking Act Reauthorization, legislation designed to prevent underage drinking.
Cigna Corporation and HealthSpring, Inc. today announced that they have signed a definitive agreement under which Cigna will acquire all the outstanding shares of HealthSpring for $55 per share in cash, a 37% premium over the closing stock price on Friday October 21, 2011, representing a total transaction value of approximately $3.8 billion.
American Pharmaceutical Partners, Inc. today announced it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Cladribine Injection.
› Verified 4 days ago
Cardio Care Inc. Location: 5917 North Lincoln Avenue, Chicago, Illinois 60659 Ratings: Phone: (773) 989-8117 | |
Nightengale Of Chicago Inc. Location: 11722 South Western Avenue, Chicago, Illinois 60643 Ratings: NA Phone: (773) 445-2378 | |
Caring Professionals Home Care Location: 3450 - 3456 W Peterson Avenue, Chicago, Illinois 60659 Ratings: Phone: (773) 588-5700 | |
Apple Home Healthcare Location: 123 W Madison Street, Suite 300, Chicago, Illinois 60602 Ratings: Phone: (773) 871-8700 | |
Crown Home Health Agency, Inc. Location: 6336 N Cicero Ave, Ste 202, Chicago, Illinois 60646 Ratings: Phone: (773) 481-1353 | |
Comprehensive Home Care Inc. Location: 6321 North Avondale Ave. Suite, Chicago, Illinois 60631 Ratings: Phone: (773) 774-5944 |